Eli Lilly’s highly anticipated weight loss drug retatrutide may also do wonders for people’s restless nights, recent research shows.

Last week, researchers published two trials of retatrutide looking at how it affected people with obstructive sleep apnea. In both trials, the experimental drug significantly reduced symptoms compared to a placebo, they found. The findings are the latest to suggest that effective weight loss treatments like retatrutide and similar GLP-1 drugs can also help manage sleep apnea.

More than one indication

Retatrutide is part of the next generation of obesity and diabetes medications that leverage certain kinds of hunger-related hormones like GLP-1. Retatrutide in particular mimics GLP-1, GIP, and the hormone glucagon.

Large-scale randomized, placebo-controlled, and double-blinded studies so far have shown that retatrutide may be the most potent obesity drug developed yet.…